Last updated: 2026-09-09 04:52:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Eton Pharmaceutcials, Inc. (ETON) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $59,31, with a market capitalization of $1,67B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $14,27 to $66,37. This page covers its latest market performance, valuation, price trends and company information.
$1,67B | |
$57,37 | |
$66,37 | |
$1,95 | |
$58,45 | |
321,79K | |
549,56K | |
-- | |
$66,37 | |
$14,27 | |
-- | |
-- |
Eton Pharmaceutcials, Inc. (ETON) last closed at $58,45 as of 2026-09-08 23:48:00, unchanged from the previous close of $58,45.
During the latest regular trading session, ETON traded between $1,95 and $66,37, with a volume of 321,79K shares. The closing price was near the upper end and near the upper end of its 52-week range.
Over the past seven days, Eton Pharmaceutcials, Inc. (ETON) moved from $62,67 to $59,31, representing a decline of 5,36% ($3,36).
The stock traded between $56,17 and $63,26 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.
The average daily volume was 566,32 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 86,4%
ETON is currently trading at $59,31, placing it 86,4% of the way from its 52-week low of $14,27 to its 52-week high of $66,37. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 44 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Eton Pharmaceutcials, Inc. (ETON) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.